Dramatic response under combination of immune-oncology in head & neck cancer included in the Condor study: A case report

被引：0
|
作者：
Daste, Amaury [1 ]
Digue, Laurence [1 ]
Ravaud, Alain [1 ,2 ]
Domblides, Charlotte [1 ,2 ,3 ]
机构：
[1] Bordeaux Univ, Hosp CHU Bordeaux, Hop St Andre, Dept Med Oncol, Bordeaux, France
[2] Univ Bordeaux, Bordeaux, France
[3] Bordeaux Univ, CNRS, ImmunoConcEpt, UMR 5164, F-33076 Bordeaux, France
来源：
ORAL ONCOLOGY | 2019年 / 89卷
关键词：
SQUAMOUS-CELL CARCINOMA; NIVOLUMAB; RECURRENT;
D O I：
10.1016/j.oraloncology.2019.01.002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：150 / 152
页数：3
相关论文
共 36 条
  • [31] Immune-related saliva micro-RNA's to predict clinical response to a combination of cetuximab and low-dose chemotherapy in head and neck cancer (HNSCC) patients (pts) with poor performance status (PS).
    Bonomi, Marcelo Raul
    Ado, Safoa
    Kooshki, Mitra
    Ahmed, Tamjeed
    Sullivan, Christopher
    Waltonen, Joshua
    Triozzi, Pierre
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [32] Phase 3 Trial of Domiciliary Humidification to Mitigate Acute Mucosal Toxicity During Radiation Therapy for Head-and-Neck Cancer: First Report of Trans Tasman Radiation Oncology Group (TROG) 07.03 RadioHUM Study
    Macann, Andrew
    Fua, Tsien
    Milross, Chris G.
    Porceddu, Sandro V.
    Penniment, Michael
    Wratten, Chris
    Krawitz, Hedley
    Poulsen, Michael
    Tang, Colin I.
    Morton, Randall P.
    Hay, K. David
    Thomson, Vicki
    Bell, Melanie L.
    King, Madeleine T.
    Fraser-Browne, Carol L.
    Hockey, Hans-Ulrich P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 88 (03): : 572 - 579
  • [33] Long-term survival data and prognostic factors of a complete response to chemotherapy in patients with head and neck cancer treated with platinum-based induction chemotherapy: A Hellenic co-operative oncology group study
    Fountzilas, G
    Kosmidis, P
    Avramidis, V
    Nikolaou, A
    KalogeraFountzila, A
    Makrantonakis, P
    Bacoyiannis, C
    Samantas, E
    Skarlos, D
    Daniilidis, J
    MEDICAL AND PEDIATRIC ONCOLOGY, 1997, 28 (06): : 401 - 410
  • [34] EGFR STATUS AND/OR ERCC1 PROTEIN EXPRESSION DO NOT PREDICT RESPONSE TO CONCOMITANT RADIATION THERAPY (RT) AND WEEKLY CETUXIMAB AND CISPLATIN IN LOCALLY ADVANCED HEAD AND NECK CANCER (LA-HNC). A HELLENIC COOPERATIVE ONCOLOGY GROUP STUDY
    Lambaki, S.
    Bobos, M.
    Kalogera-Fountzila, A.
    Aravantinos, G.
    Skarlos, D.
    Misailidou, D.
    Samantas, E.
    Murray, S.
    Kalogeras, K. T.
    Fountzilas, G.
    ANNALS OF ONCOLOGY, 2008, 19 : 223 - 223
  • [35] A randomized phase II study evaluating concurrent or sequential fixed-dose immune therapy in combination with cisplatin and intensity-modulated radiotherapy in intermediate- or high-risk, previously untreated, locally advanced head and neck cancer (LA SCCHN).
    Clump, David Anthony
    Zandberg, Dan Paul
    Skinner, Heath Devin
    Ohr, James
    Fenton, Moon Jung
    Normolle, Daniel Paul
    Beitler, Jonathan Jay
    Bauman, Julie E.
    Ferris, Robert L.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [36] COMBINED SURGERY AND RADIATION-THERAPY VS DEFINITIVE RADIATION-THERAPY WITH SURGICAL RESCUE FOR PERSISTENT DISEASE IN PATIENTS WITH ADVANCED SQUAMOUS-CELL HEAD AND NECK-CANCER - FINAL REPORT OF STUDY 73-03 OF THE RADIATION-THERAPY-ONCOLOGY-GROUP
    KRAMER, S
    GELBER, RD
    SNOW, JB
    MARCIAL, VA
    LOWRY, LD
    DAVIS, LE
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1983, 6 (02): : 147 - 148
1234